Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-16-060377

Director sold 14,685 shares at an average $35.35 ($519,105)

  • Director acquired 8,580 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

FOOTE SUSAN BARTLETT · Director

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2016-08-05 Sale : show line 1 in the form −300 $35.36 $10,607 16,311 D
2016-08-05 Sale : show line 2 in the form −8,280 $35.35 $292,698 16,611 D
2016-08-05 Exercise or conversion : show line 3 in the form +8,580 $27.24 $233,719 24,891 D
2016-08-05 Sale : show line 4 in the form −5,305 $35.35 $187,532 16,311 D
2016-08-05 Sale : show line 5 in the form −200 $35.35 $7,069 21,616 D
2016-08-05 Sale : show line 6 in the form −300 $35.34 $10,602 21,816 D
2016-08-05 Sale : show line 7 in the form −200 $35.33 $7,066 22,116 D
2016-08-05 Sale : show line 8 in the form −100 $35.32 $3,532 22,316 D
Open-market sales · 14,685 sh · avg $35.35 · $519,105

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-08-05 Exercise or conversion : show line 9 in the form Non-qualified Stock Option (Right to Buy) −8,580 0 D
Loading xslF345X03/form4.xml…